Your browser doesn't support javascript.
loading
Efficacy and Safety of the Modified EPOCH Regimen (Etoposide, Vincristine, Doxorubicin, Carboplatin, and Prednisolone) for Adult T-cell Leukemia/Lymphoma: A Multicenter Retrospective Study.
Tsukamoto, Yasuhiro; Kiyasu, Junichi; Choi, Ilseung; Kozuru, Mitsuo; Uike, Naokuni; Utsunomiya, Hayato; Hirata, Akie; Fujioka, Eriko; Ohno, Hirofumi; Nakashima, Eriko; Nakashima, Yasuhiro; Miyashita, Kaname; Tachikawa, Yoshimichi; Narazaki, Taisuke; Tsuda, Mariko; Haji, Shojiro; Takamatsu, Akiko; Tanaka, Emi; Goto, Tatsuro; Takatsuki, Hiroshi; Oyama, Makoto; Muta, Hiroki; Yagi, Yu; Ikeda, Motohiko; Matsushima, Takamitsu; Yufu, Yuji; Suehiro, Youko.
Afiliação
  • Tsukamoto Y; Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka-city, Fukuoka, Japan; Department of Hematology, Iizuka Hospital, Iizuka-city, Fukuoka, Japan.
  • Kiyasu J; Clinical Research Institute, National Hospital Organization Kyushu Cancer Center, Fukuoka-city, Fukuoka, Japan; Department of Hematology, Iizuka Hospital, Iizuka-city, Fukuoka, Japan; Department of Pathology, Kurume University, Kurume-city, Fukuoka, Japan. Electronic address: jkiyasuh2@aih-net.com.
  • Choi I; Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka-city, Fukuoka, Japan.
  • Kozuru M; Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka-city, Fukuoka, Japan.
  • Uike N; Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka-city, Fukuoka, Japan.
  • Utsunomiya H; Cell Therapy, National Hospital Organization Kyushu Cancer Center, Fukuoka-city, Fukuoka, Japan.
  • Hirata A; Clinical Laboratory Medicine, National Hospital Organization Kyushu Cancer Center, Fukuoka-city, Fukuoka, Japan.
  • Fujioka E; Cell Therapy, National Hospital Organization Kyushu Cancer Center, Fukuoka-city, Fukuoka, Japan.
  • Ohno H; Cell Therapy, National Hospital Organization Kyushu Cancer Center, Fukuoka-city, Fukuoka, Japan.
  • Nakashima E; Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka-city, Fukuoka, Japan.
  • Nakashima Y; Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka-city, Fukuoka, Japan.
  • Miyashita K; Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka-city, Fukuoka, Japan.
  • Tachikawa Y; Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka-city, Fukuoka, Japan.
  • Narazaki T; Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka-city, Fukuoka, Japan.
  • Tsuda M; Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka-city, Fukuoka, Japan.
  • Haji S; Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka-city, Fukuoka, Japan.
  • Takamatsu A; Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka-city, Fukuoka, Japan.
  • Tanaka E; Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka-city, Fukuoka, Japan.
  • Goto T; Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka-city, Fukuoka, Japan.
  • Takatsuki H; Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka-city, Fukuoka, Japan.
  • Oyama M; Department of Hematology, Iizuka Hospital, Iizuka-city, Fukuoka, Japan.
  • Muta H; Department of Hematology, Iizuka Hospital, Iizuka-city, Fukuoka, Japan.
  • Yagi Y; Department of Hematology, Iizuka Hospital, Iizuka-city, Fukuoka, Japan.
  • Ikeda M; Department of Hematology, Iizuka Hospital, Iizuka-city, Fukuoka, Japan.
  • Matsushima T; Department of Hematology, Iizuka Hospital, Iizuka-city, Fukuoka, Japan.
  • Yufu Y; Department of Hematology, Iizuka Hospital, Iizuka-city, Fukuoka, Japan.
  • Suehiro Y; Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka-city, Fukuoka, Japan; Cell Therapy, National Hospital Organization Kyushu Cancer Center, Fukuoka-city, Fukuoka, Japan.
Clin Lymphoma Myeloma Leuk ; 20(7): e445-e453, 2020 07.
Article em En | MEDLINE | ID: mdl-32312633
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma de Células T do Adulto / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Lymphoma Myeloma Leuk Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma de Células T do Adulto / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Lymphoma Myeloma Leuk Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão